Results 1 to 10 of about 10,983,225 (406)

The Immunological Basis of Dry Eye Disease and Current Topical Treatment Options. [PDF]

open access: yesJournal of Ocular Pharmacology and Therapeutics, 2020
Homeostasis of the lacrimal functional unit is needed to ensure a well-regulated ocular immune response comprising innate and adaptive phases. When the ocular immune system is excessively stimulated and/or immunoregulatory mechanisms are disrupted, the ...
Lin, Meng C   +4 more
core   +3 more sources

THE TREATMENT OF DISEASES OF THE EYE [PDF]

open access: greenThe American Journal of the Medical Sciences, 1906
n ...
VICTOR HANKE
openalex   +4 more sources

A Review on Dry Eye Disease Treatment: Recent Progress, Diagnostics, and Future Perspectives

open access: yesPharmaceutics, 2023
Dry eye disease is a multifactorial disorder of the eye and tear film with potential damage to the ocular surface. Various treatment approaches for this disorder aim to alleviate disease symptoms and restore the normal ophthalmic environment.
Himangsu Mondal   +3 more
semanticscholar   +1 more source

Features of regression of different stages of retinoblastoma after primary combined (intravitreal plus systemic) polychemotherapy and additional consolidation therapy

open access: yesJournal of Ophthalmology, 2023
Background: Complete retinoblastoma (RB) regression is defined as final changes undergone by the tumor in the course of eye-salvage treatment. Studies of RB regression patterns following various types of eye-salvage treatment are important for assessing ...
Nadiya Bobrova   +6 more
doaj   +1 more source

miR-204–containing exosomes ameliorate GVHD-associated dry eye disease

open access: yesScience Advances, 2022
MSC-exo eye drops alleviate GVHD-associated dry eye disease by shifting M1 macrophages to M2 via miR-204.
Tian Zhou   +13 more
semanticscholar   +1 more source

Hyaluronic acid in the treatment of dry eye disease

open access: yesActa ophthalmologica, 2022
Dry eye disease (DED) is a highly prevalent and debilitating condition affecting several hundred million people worldwide. Hyaluronic acid (HA) is a naturally occurring glycosaminoglycan commonly used in the treatment of DED.
Leif Hynnekleiv   +7 more
semanticscholar   +1 more source

Dry eye disease: identification and therapeutic strategies for primary care clinicians and clinical specialists

open access: yesAnnals medicus, 2022
Dry eye disease (DED) is a multifactorial disorder characterized by loss of tear film homeostasis with an estimated worldwide prevalence of 5% to 50%.
J. Sheppard   +2 more
semanticscholar   +1 more source

Evaluation of the Impact of Mid-Infrared Laser Radiation on Eye Tissues (Experimental Study)

open access: yesOftalʹmologiâ, 2023
Purpose — to study the effect of a mid-infrared laser with a wavelength of 3.0 μm on the eye tissue. Materials and methods. An experimental laser device “Laser scalpel in the middle infrared range 2–8 μm for precision surgery” was used.
Yu. N. Yusef   +4 more
doaj   +1 more source

Precise in vivo adaptive optics imaging of retinal vessels

open access: yesJournal of Ophthalmology, 2023
Adaptive optics (AO) provides new, unique opportunities for in vivo visualization of retinal vasculature. AO retinal vessel imaging can be utilized as a component of multimodal imaging tools to complement conventional diagnostic imaging modalities.
Oleg Zadorozhnyy   +5 more
doaj   +1 more source

Teprotumumab for the treatment of chronic thyroid eye disease

open access: yesEye, 2021
Teprotumumab, a novel IGF-1R antibody was recently shown to significantly reduce the signs of active Thyroid eye disease (TED). The current study reviews its efficacy in chronic TED.
Shoaib Ugradar   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy